TRDA Operating Cash Flow (Statement)
Entrada Therapeutics Inc · Operating Cash Flow (Statement)
TRDA Operating Cash Flow (Statement)
Latest reported-$134.67Mperiod ending
TRDA Cash from Operations (-$10.80M → -$134.67M)
Annual operating cash flow (statement)
High-resolution chart · PNG
TRDA operating cash flow (statement) history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -128,512,000 | |
| -41,557,000 | |
| 139,803,000 | |
| -93,786,000 | |
| -50,862,000 | |
| -25,570,000 | |
| -10,801,000 |